GnRH Agonist and Intrauterine Insemination
Phase 4
Completed
- Conditions
- Intrauterine Insemination
- Registration Number
- NCT00503217
- Lead Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA
- Brief Summary
The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Women < 38 years old
- Bilateral tubal patency confirmed by hysterosonography
- Normal ultrasound scan of uterus and ovaries
- Normal day 3 basal hormones
- Motile sperm count after capacitation ≥ 3 mill/ml
Exclusion Criteria
- Endometriosis
- Polycystic ovary syndrome
- Uterine disease (polyps, myomas and müllerian diseases)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Instituto Valenciano de Infertilidad Spain
🇪🇸Valencia, Spain
Instituto Valenciano de Infertilidad Spain🇪🇸Valencia, Spain